Application of BAPTA derivative in the preparing process of clinical medicine

A technology of derivatives and drugs, which is applied in the application field of BAPTA derivatives in the preparation of clinical drugs, can solve the problems of no BAPTA derivatives medicinal research, can not be used in human body, and unsolved key problems of pharmacy, so as to reduce the blood pressure of blood vessels. Permeability, inhibition of cerebral edema, and effect of reducing brain index

Inactive Publication Date: 2006-09-06
HENGXING PHARMA INST HEFEI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These poisonous solvents cannot be used in human body. Due to unresolved key issues in pharmacy, there is no report of BAPTA derivatives as medicinal research so far.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of BAPTA derivative in the preparing process of clinical medicine
  • Application of BAPTA derivative in the preparing process of clinical medicine
  • Application of BAPTA derivative in the preparing process of clinical medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0028] Non-limiting examples are described as follows:

[0029] 1. Preparation of liposomes

[0030] Dissolve 0.1mmol of phospholipid, 0.1mmol of cholesterol and 0.08mmol of BAPTA-AM (hereinafter referred to as TM) in chloroform, and use a thin film rotary evaporator to decloud the chloroform under vacuum. A uniform dry film is attached to the wall of the device, and then add phosphoric acid micro Wash solution or Tris buffer solution, and use ultrasonic treatment until the solution is clear and transparent.

[0031] 2. Preparation of microcapsules:

[0032] Mix and stir TM and gelatin aqueous solution to obtain an o / w emulsion, raise the temperature to 50°C, add dilute acetic acid to adjust the pH to about 3.5, add Na 2 SO 4 solution to condense into microcapsules and disperse in the emulsion, and continue to add Na 2 SO 4 The solution causes the microcapsules to settle, cool down to below 15°C, add formaldehyde solution, adjust the pH to 8-9 with NaOH to solidify the mi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention features that BAPTA derivative is applied in preparing medicine for treating acute great area cell death clinically. The medicine is prepared into particle preparation for the clinical salvage and treatment of acute great area cell death diseases, such as cerebral infarction, myocardial infarction, liver necrosis, ischemic kidney necrosis, necrotic pencreatitis, etc.

Description

1. Technical field [0001] The present invention relates to a novel use of a derivative of a known compound, specifically the application of BAPTA and its derivatives in the preparation of clinical medicines. It is used for the rescue and treatment of patients with acute massive cell death. 2. Background technology [0002] Ischemia and hypoxia are the main causes of acute mass cell death in the human body, such as ischemic stroke and myocardial infarction leading to the death of brain cells and cardiomyocytes. In recent years, the research on the mechanism of cell death related to ischemia and hypoxia has made great progress, which points out the direction and provides a theoretical basis for the research and development of powerful drugs to protect cells from death. [0003] Mr. Zhang Juntian, a famous pharmacologist, discussed intracellular calcium overload in the book "Modern Pharmacological Experimental Methods" and pointed out that intracellular calcium overload caused...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/195A61K31/21A61P43/00A61P9/10A61K31/205A61K31/225
CPCA61K31/195A61K31/205A61K31/225A61P9/10A61P39/04A61P43/00
Inventor 宋必卫刘经星魏伟
Owner HENGXING PHARMA INST HEFEI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap